SureSelect Cancer Tumor-Specific Assays

SureSelect Cancer Tumor-Specific assays offer genomic profiling for solid tumors from lung, colon, pancreas, kidney, or bladder tissue, to detect single nucleotide variants (SNVs), copy number variants (CNVs), insertions/deletions (indels), and translocations (TLs). These small cancer panels enable affordable tumor genomic profiling. Powered by SureSelect XT HS2 library preparation and target enrichment reagents, the assays feature fast hybridization, low sample input, enzymatic fragmentation, and a one-day workflow to generate NGS sequencing-ready libraries. Automation options reduce hands-on time to maximize lab efficiency.